Eltrombopag Olamine Tablet, Film Coated
Product Images NDC 69238-1415

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eltrombopag Olamine (NDC 69238-1415). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Eltrombopag Tablets Us 1)

FDA Label Image

12.5mg 30ct Label (Eltrombopag Tablets Us 2)

12.5mg 30ct Label (Eltrombopag Tablets Us 2)
This text provides information on a medication called Eltrombopag, with each film-coated tablet containing Eltrombopag Olamine 15.95 mg, which is equivalent to 12.5 mg of Eltrombopag free acid. The recommended dosage and storage instructions are included, such as storing the tablets at room temperature and not spitting, chewing, or crushing them. The text also mentions the importance of using safety closures and not using the product if the printed safety seal under the cap is broken or missing. The medication is distributed by Amneal Pharmaceuticals LLC.*
FDA Label Image

25mg 30ct Label (Eltrombopag Tablets Us 3)

25mg 30ct Label (Eltrombopag Tablets Us 3)
Description: This text contains information on Eltrombopag tablets, with details on dosage, storage instructions, safety precautions, and distribution information provided by Amneal Pharmaceuticals LLC. It also mentions the importance of keeping the medication guide and safety seal intact and out of reach of children. Please refer to accompanying prescribing information for recommended dosage details. The tablets contain Eltrombopag equivalent to 102.5 mg of Eltrombopag free acid. Storage should be at room temperature between 20° - 25°C (68° - 77°F).*
FDA Label Image

50mg 30ct Label (Eltrombopag Tablets Us 4)

50mg 30ct Label (Eltrombopag Tablets Us 4)
The text provides information about a medication called Eltrombopag in tablet form. It includes the dosage, storage instructions, precautions, and details on distribution by Amneal Pharmaceuticals. The medication guide should be provided to each patient. It is important to use safety closures when dispensing the product and keep it out of reach of children. The tablets contain Eltrombopag dosed at 63.80 mg. The recommended storage temperature is between 20°C to 25°C, with excursions permitted between 15°C to 30°C.*
FDA Label Image

75mg 30ct Label (Eltrombopag Tablets Us 5)

75mg 30ct Label (Eltrombopag Tablets Us 5)
This text provides information about a medication containing 75 mg of eltrombopag disodium in a film-coated tablet form. It includes dosing recommendations, storage instructions, and precautions about not splitting, chewing, or crushing the tablets. The medication should be dispensed in its original bottle, and it is important not to use it if the safety seal under the cap is broken or missing. The text also mentions the manufacturer, Amneal Pharmaceuticals, and Rx only.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.